Video

Thyroid Dysfunction: Relation to Radiation Dose

Researchers examined the correlation between radiation dose for head and neck cancer and subsequent thyroid dysfunction.

Radiation therapy for cancer and development of hypothyroidism: what are the predictive risks?

A study in the journal Head and Neck reviewed the records of 102 patients who received radiation therapy for head and neck cancer.

Permanent dysfunction was seen in 24.5%, with a significantly higher incidence in women. Concurrent chemotherapy increased the risk of permanent dysfunction.

There was a significant correlation between the volume of thyroid receiving greater than 50 Gy and subsequent thyroid dysfunction.

The author’s conclusions: radiotherapy-induced thyroid dysfunction is clearly dose related; the authors recommended a mean dose of less than 54.58 Gy, noting female sex and concurrent chemotherapy add to the predictive risk.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
© 2025 MJH Life Sciences

All rights reserved.